SGMT · Forms 3, 4, 5
Insider trades at Sagimet Biosciences Inc.
1 insider sold $3.8M of Sagimet Biosciences Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Sagimet Biosciences Inc. (SGMT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| George Kemble | Director | Option exercise | 326,618 | $6.36 | $2.1M | Form 4 | |
| George Kemble | Director | Option exercise | 24,369 | $6.36 | $155K | Form 4 | |
| George Kemble | Director | Sell | 350,987 | $10.23 | $3.6M | Form 4 | |
| George Kemble | Director | Option exercise | 9,751 | $6.36 | $62K | Form 4 | |
| George Kemble | Director | Option exercise | 10,455 | $6.36 | $66K | Form 4 | |
| George Kemble | Director | Sell | 20,206 | $9.95 | $201K | Form 4 | |
| David Happel | President & CEO | Sell | 64,051 | $7.76 | $497K | Form 4 | |
| Elizabeth Rozek | Chief Legal & Admin. Officer | Sell | 10,545 | $7.76 | $82K | Form 4 | |
| George Kemble | Director | Sell | 18,844 | $7.46 | $141K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.